We focus on companies striving to disrupt how drugs are developed, diseases are diagnosed, and patients are treated. We seek innovative companies targeting significant, unmet medical needs, with a focus on oncology, rare diseases, and antimicrobial resistance.
Kineticos possesses a long history of operating, consulting, and investing in contract development and manufacturing organizations (CDMOs), equipment, and other enabling technologies.
Learn More
Kineticos invests in companies with disruptive technologies to bring their innovations to market and address other solutions for the growing burden of AMR.
Learn More
Kineticos partners and invests in biotech and medtech companies with a focus on cell and gene therapy striving to disrupt how drugs are developed and patients are treated.
Learn More
The Foundry is a launchpad for life science innovation, purpose-built to accelerate the formation of breakthrough companies. By building a powerful network of industry partners, influential life science executives, and top-tier R1 research universities, we gain early access to transformative technologies, ideas, and deals—before they hit the market.
Learn MoreKineticos provides more than capital; we leverage our operator, scientific, and financial expertise to help drive portfolio company strategy and growth. Our partnership approach delivers meaningful outcomes to patients, portfolio companies, and investors.
Kineticos seeks to partner with management teams positioned to solve these service gaps and provide solutions to the advancing biologic sector.